Vaccination against human papillomavirus: A baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs

article

Vaccination against human papillomavirus: A baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2007.08.041
P698PubMed publication ID17923173

P50authorShelly A McNeilQ56433319
P2093author name stringDeborah Money
Manale Ouakki
Vladimir Gilca
Bernard Duval
Chantal Sauvageau
France Lavoie
Simon Dobson
Ian M Gemmill
P2860cites workSustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialQ28236008
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammographyQ28295438
Epidemiologic classification of human papillomavirus types associated with cervical cancerQ29616213
Physician response to surveys. A review of the literatureQ34118126
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialQ34415030
Efficacy of the Theory of Planned Behaviour: a meta-analytic reviewQ34496742
Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists.Q35614621
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer controlQ36065397
Improving adolescent health: focus on HPV vaccine acceptanceQ36323244
Chapter 24: Psychosocial aspects of vaccine acceptability.Q36584387
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international expertsQ36584407
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upQ36612475
Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screeningQ36733146
Parental attitudes to pre-pubertal HPV vaccination.Q43611354
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialQ45552005
Attitudes about human papillomavirus vaccine among family physicians.Q51828882
Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.Q51830829
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 VaccineQ57089428
Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and controlQ73401173
Physicians' knowledge, attitudes, and practice of pharmacologic treatment of hypertensionQ77056045
P433issue45
P407language of work or nameEnglishQ1860
P921main subjectvaccination attitudeQ105046968
P304page(s)7841-7847
P577publication date2007-09-14
P1433published inVaccineQ7907941
P1476titleVaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs
P478volume25